GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
T80.82
Complication of immune effector cellular therapy
ICD10CM code
Similar Codes
ICD10CM codes
T80.82
- Complication of immune effector cellular therapy
T80.82XA
- Complication of immune effector cellular therapy, initial encounter
T80.82XD
- Complication of immune effector cellular therapy, subsequent encounter
T80.82XS
- Complication of immune effector cellular therapy, sequela
T80.89
- Other complications following infusion, transfusion and therapeutic injection
T86.5
- Complications of stem cell transplant
T80.8
- Other complications following infusion, transfusion and therapeutic injection
T80.9
- Unspecified complication following infusion, transfusion and therapeutic injection
T80.89XA
- Other complications following infusion, transfusion and therapeutic injection, initial encounter
T80.90
- Unspecified complication following infusion and therapeutic injection
HCPCS codes
Q2043
- Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leuk
J9311
- Injection, rituximab 10 mg and hyaluronidase
J0850
- Injection, cytomegalovirus immune globulin intravenous (human), per vial
S9359
- Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
Q2041
- Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, includi
J7599
- Immunosuppressive drug, not otherwise classified
J9227
- Injection, isatuximab-irfc, 10 mg
J9312
- Injection, rituximab, 10 mg
C9467
- Injection, rituximab and hyaluronidase, 10 mg
Q5102
- Injection, infliximab, biosimilar, 10 mg
CPT4 codes
88230
- Tissue culture for non-neoplastic disorders; lymphocyte
38242
- Allogeneic lymphocyte infusions
0538T
- Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes for tra
90399
- Unlisted immune globulin
86849
- Unlisted immunology procedure
86153
- Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating t
88239
- Tissue culture for neoplastic disorders; solid tumor
88237
- Tissue culture for neoplastic disorders; bone marrow, blood cells
86644
- Antibody; cytomegalovirus (CMV)
36515
- Therapeutic apheresis; with extracorporeal immunoadsorption and plasma reinfusion